Inova Health Care Services
Clinical trials sponsored by Inova Health Care Services, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Finger-Stick and phone app could replace needles for anemia in pregnancy Results expected Sep 2026 (estimated)
- Hope on video: new study tests positive messages for brain injury recovery Results expected Oct 2026 (estimated)
- New triplet therapy hopes to shrink liver tumors Results expected Oct 2026 (estimated)
- New study aims to stop Post-Birth bleeding with smarter drug dosing Results expected Nov 2026 (estimated)
- Acupuncture may cool hot flashes in men on prostate cancer hormone therapy Results expected Dec 2026 (estimated)
-
Which antibiotic works best when water breaks early?
Disease control OngoingThis study tests two common antibiotics—erythromycin and azithromycin—in pregnant people whose water breaks too early (before 34 weeks). Both are given along with standard antibiotics. The goal is to see which combination helps delay delivery longer, giving the baby more time to …
Phase 3 • Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pacemaker study aims to help heart failure patients with mildly reduced pumping function
Disease control OngoingThis study is testing whether a special pacemaker (cardiac resynchronization therapy, or CRT) can improve heart function and symptoms in people with mild heart failure and a specific type of heart block called left bundle-branch block. About 21 participants will receive a CRT dev…
Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Blood-Guided chemo dosing study for colon cancer withdrawn
Disease control CancelledThis pilot study aimed to see if adjusting the dose of the chemotherapy drug 5-FU based on its concentration in the blood could improve treatment for metastatic colorectal cancer. The study was withdrawn before enrolling any participants. It was designed for adults with metastati…
Phase 2 • Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Personalized heparin calculator aims to speed up clot treatment
Disease control OngoingThis study tests whether using a patient's gender, weight, and kidney function to calculate the starting dose of the blood thinner heparin gets patients to the right level faster than the standard flat rate. About 145 adults with blood clots, atrial fibrillation, or mechanical he…
Phase 4 • Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Exercise coaching may ease fatigue during radiation for endometrial cancer
Symptom relief OngoingThis study tests whether a personalized activity coaching program can help women feel less tired during pelvic radiation therapy for endometrial cancer. Sixteen participants will be randomly assigned to receive coaching or usual care. The main goal is to see if the program is pra…
Sponsor: Inova Health Care Services • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New device aims to solve feeding problems in ICU patients with organ failure
Symptom relief OngoingThis study tests whether a device called RELiZORB™ can help critically ill adults with multiple organ failure better tolerate tube feedings. The device breaks down fats in the feeding to make them easier to digest. Researchers will compare how well patients meet their nutrition g…
Sponsor: Inova Health Care Services • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Hope on video: new study tests positive messages for brain injury recovery
Knowledge-focused By invitation onlyThis study is testing whether a short educational video that gives positive reassurance can improve recovery in people with mild traumatic brain injury (mTBI). Researchers will enroll 229 participants aged 13-21 who were diagnosed with mTBI in the emergency department. The goal i…
Sponsor: Inova Health Care Services • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC